This is a difficult area of PCT practice because of the frequent lack of clarity and the highly charged, emotive nature of the applications. We would urge all those involved in these processes to collaborate with commissioners, clinicians and legal advisors to establish common understanding of the principles and share best practice. _______________ NW PCT Medicines and Treatments Group 8th April 2009 Acknowledgements and thanks This guidance has been developed with the assistance of the following: Specialist in Public Health, North West Specialised Dr. Claire O’Donnell, Clinical Effectiveness Commissioning Team Dr. Sally Nelson, Consultant in Public Health, South Central Specialised Commissioning Team Dr Corinne Camilleri-Ferrante, Consultant in Public Health, Derbyshire PCT Dr Ash Paul, Medical Director, Bedfordshire PCT Dr Jonathan Howell, Consultant in Public Health, Specialised Commissioning Team Dr Daphne Austin, Consultant in Public Health, Specialised Commissioning Team Dr Mark Lambert, Consultant in Public Health, South of and Wear PCTs and Fellow of the NHS Institute of Innovation. Dr Nicholas Hicks, National Coordinating Centre for Health Technology Assessment Dr Gary Cook, Consultant Epidemiologist and Head of Clinical Effectiveness Unit, NHS Foundation Trust References 1Priority setting: an overview; Priority setting: managing new treatments; Priority setting: legal considerations 2008 NHS Confederation Publications. Available from www.nhsconfed.org/publications 2 Priority setting: managing individual funding requests. Available from www.nhsconfed.org/publications
This is a difficult area of PCT practice because of the frequent lack of clarity and the highly charged, emotive nature of the applications. We would urge all those involved in these processes to collaborate with commissioners, clinicians and legal advisors to establish common understanding of the principles and share best practice. _______________ NW PCT Medicines and Treatments Group 8th April 2009 Acknowledgements and thanks This guidance has been developed with the assistance of the following: Dr. Claire O’Donnell, Clinical Effectiveness Specialist in Public Health, North West Specialised Commissioning Team Dr. Sally Nelson, Consultant in Public Health, South Central Specialised Commissioning Team Dr Corinne Camilleri-Ferrante, Consultant in Public Health, Derbyshire PCT Dr Ash Paul, Medical Director, Bedfordshire PCT Dr Jonathan Howell, Consultant in Public Health, Specialised Commissioning Team Dr Daphne Austin, Consultant in Public Health, Specialised Commissioning Team Dr Mark Lambert, Consultant in Public Health, South of and Wear PCTs and Fellow of the NHS Institute of Innovation. Dr Nicholas Hicks, National Coordinating Centre for Health Technology Assessment Dr Gary Cook, Consultant Epidemiologist and Head of Clinical Effectiveness Unit, NHS Foundation Trust References 1Priority setting: an overview; Priority setting: managing new treatments; Priority setting: legal considerations 2008 NHS Confederation Publications. Available from www.nhsconfed.org/publications 2 Priority setting: managing individual funding requests. Available from www.nhsconfed.org/publications
GMMMG-PBR-Exclusions-2017-19-supporting-information-1-0.docx